HER2/neu-directed therapy for biliary tract cancer

BACKGROUND: Biliary cancers are highly aggressive tumors that are often diagnosed an advanced disease stage and have a poor outcome with systemic therapy. Recent efforts towards molecular characterization have identified a subset of biliary patients that have HER2/neu amplification or mutation. HER2...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Javle, Milind, Churi, Chaitanya, Kang, HyunSeon C., Shroff, Rachna, Janku, Filip, Surapaneni, Rakesh, Zuo, Mingxin, Barrera, Christian, Alshamsi, Humaid, Krishnan, Sunil, Mishra, Lopa, Wolff, Robert A., Kaseb, Ahmed O., Thomas, Melanie B., Siegel, Abby B.
Formáid: Online Alt Téacs
Teanga:English
Foilsithe / Cruthaithe: BioMed Central 2015
Ábhair:
Research Article
Rochtain ar líne:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469402/
https://www.ncbi.nlm.nih.gov/pubmed/26022204
http://dx.doi.org/10.1186/s13045-015-0155-z

Ar líne

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469402/
https://www.ncbi.nlm.nih.gov/pubmed/26022204
http://dx.doi.org/10.1186/s13045-015-0155-z

Míreanna comhchosúla